Prevalencia de trastornos sexuales en mujeres con cáncer ginecológico en el departamento del Quindío

Franklin José Espitia-De La Hoz

Resumen


 

Introducción: los estudios epidemiológicos señalan que los trastornos sexuales son comunes en hombres y mujeres de todas las edades y sociedades, pero son más frecuentes en personas mayores y en las que padecen enfermedades crónicas, incluyendo la depresión y el cáncer.

Objetivo: conocer la prevalencia de trastornos sexuales en pacientes con cáncer ginecológico en una población de mujeres del Quindío - Colombia.

Resultados: estudio en 207 mujeres. El cáncer de mama representó 36.2% del total, endometrio 18.8%, cérvix 26.0%, ovario 11.5% y vulva 7.2%. Los trastornos sexuales se detectaron en el 48.9% del grupo con edades entre 20-40 años, en 58.8% en el de 41-60 y en 96.3% de las mujeres entre 61-80 años de edad, siendo del 100% en las mayores de 80 años. La prevalencia de trastornos sexuales fue del 94.2% en este grupo de mujeres.

Conclusión: la prevalencia de trastornos sexuales es elevada entre mujeres con cáncer ginecológico. La angustia acerca de los trastornos sexuales es más del doble de prevalente entre las mujeres con cáncer de vulva o cérvix. En contraste, las pacientes con cáncer de mama presentaron menores porcentajes de dificultades sexuales, pero no por eso deja de ser importante, puesto que las cifras continúan siendo superiores a las de la comunidad no oncológica. Rev.cienc.biomed. 2016:7(2):203-211.

PALABRAS CLAVE

Cáncer; Mujeres; Orgasmo; Prevalencia; Sexualidad.

 

SUMMARY

Introduction: epidemiological studies point out that sexual disorders are common in men and women of all ages, but they are more frequent in adults and in those people who are suffering chronic diseases, including depression and cancer.

Objective: to know the prevalence of sexual disorders associated with gynecological cancer among a women group from Quindio – Colombia.

Results: 207 cases were found. The breast cancer accounted for 36.2% of the total; endometrial cancer 18.8%; cervix cancer 26%, ovarian cancer 11.5% and vulvar cancer 7.2%. Sexual disorders were detected in 48.9% of the group aged 20-40 years, 58.8% in the 41-60 age group, and in 96.3% of the women between 61 and 80 years of age, being 100% in the elderly of 80 years. The prevalence of sexual disorders was 94.2% in this group of women.

Conclusion: the prevalence of sexual disorders rises among women with gynecological cancer. The concern about sexual disorders is more than twice as prevalent among women with vulvar and cervix cancer. In contrast, the women who suffering from breast cancer show lower percentages of sexual disorders, but that has the same importance because the numbers of these diseases are higher than those of the non-cancer community. Rev.cienc.biomed. 2016:7(2):203-211.

KEYWORDS

Cancer; Women; Orgasm; Prevalence; Sexuality.


Texto completo:

Sin título

Referencias


Tozo IM, Lima SMRR, Gonçalves N, Moraes JC, Aoki T. Disfunção sexual feminina: a importância do conhecimento e do diagnóstico pelo ginecologista. Arq Med Hosp Fac Cienc Med Santa Casa São Paulo 2007; 52:94-99.

Basson R. Women’s sexual dysfunction: revised and expanded definitions. CMAJ. 2005;172(10):1327-33.

Nicolosi A, Laumann EO, Glasser DB, Moreira ED, Paik A, Gingell C. Sexual behavior and sexual dysfunctions after age 40: the global study of sexual attitudes and behaviors. Urology. 2004;64(5):991-97.

Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States. JAMA. 1999;281(6):537-44.

Mercer CH, Fenton KA, Johnson AM, Wellings K, Macdowall W, McManus S, Nanchahal K, Erens B: Sexual function problems and help seeking behavior in Britain: national probability sample survey. BMJ. 2003;327:426-27.

Lewis RW, Fugl-Meyer KS, Corona G, Hayes RD, Laumann EO, Moreira ED Jr, Rellini AH, Segraves T. Definitions/epidemiology/risk factors for sexual dysfunction,” Journalof Sexual Medicine. 2010;7(4):1598–607.

Schavelzon J. Desadaptación afectiva, sexualidad y cáncer. En: Schavelzon J, ed. Psique. Buenos Aires: Científica Interamericana 1992;1:258-74.

Cleary V, Hegarty J. Understanding sexuality in women with gynaecological cancer. Eur J Oncol Nurs 2011;15:38-45.

Anllo LM. Sexual life after breast cancer. J Sex Marital Ther 2000;26:241–48.

Greenwald HP, McCorkle R. Sexuality and sexual function in long-term survivors of cervical cancer. J Womens Health (Larchmt). 2008;17:955-63.

Bartoces MG, Severson RK, Rusin BA, Schwartz KL, Ruterbusch JJ, Neale AV. Quality of life and self-esteem of long-term survivors of invasive and noninvasive cervical cancer. J Womens Health (Larchmt). 2009;18:655-61.

Jensen PT, Groenvold M, Klee MC, Thranov I, Petersen MA, Machin D. Early-stage cervical carcinoma, radical hysterectomy, and sexual function. A longitudinal study. Cancer. 2004;100:97-106.

Dursun P, Ayhan A, Kuscu E. Nerve-sparing radical hysterectomy for cervical carcinoma. Crit Rev Oncol Hematol. 2009;70:195-205.

Duarte TP, Andrade AN. Enfrentando a mastectomia: análise dos relatos de mulheres mastectomizadas sobre questões ligadas à sexualidade. Estud Psicol. 2003;8(1):155-63.

Derzko C,Elliot S, Lam W. Management of sexual dysfunction in postmenopausal breast cancer patients taking adjuvant aromatase inhibitor therapy. Curr Oncol. 2007;14:20-40.

Fallowfield LJ, Bliss JM, Porter LS et al. Quality of life in the intergroup exemestane study: a randomised trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in postmenopausal women with primary breast cancer. J Clin Oncol. 2006;24:910-17.

Rogers M, Kristjanson LK. The impact on sexual functioning of chemotherapy induced menopause in women with breast cancer. Cancer Nurs. 2002;25(1):57-65.

Okanami Y, Ito Y, Watanabe C et al. Incidence of chemotherapy-induced amenorrhea in premenopausal patients with breast cancer following adjuvant antracycline and taxane. Breast Cancer. 2011;18:182-188.

Fobair P, Spiegel D. Concerns about sexuality after breast cancer. The Cancer Journal 2009;15(1):19-26.

Barker CL, Routledge JA, Farnell DJ, Swindell R, Davidson SE. The impact of radiotherapy late effects on quality of life in gynaecological cancer patients. Br J Cancer 2009;100:1558-65.

Donovan KA, Taliaferro LA, Alvarez EM, Jacobsen PB, Roetzheim RG, Wenham RM. Sexual health in women treated for cervical cancer: characteristics and correlates. Gynecol Oncol. 2007;104:428-34.

Carter J, Penson R, Barakat R, Wenzel L. Contemporary quality of life issues affecting gynecologic cancer survivors. Hematol Oncol Clin North Am. 2012;26:169-94.

Herzog TJ, Wright JD. The impact of cervical cancer on quality of life--the components and means for management. Gynecol Oncol. 2007;107:572-77.

Ratner ES, Foran KA, Schwartz PE, Minkin MJ. Sexuality and intimacy after gynecological cancer. Maturitas. 2010;66:23-6.

White ID. The assessment and management of sexual difficulties after treatment of cervical and endometrial malignancies. Clin Oncol. (R Coll Radiol) 2008;20:488-96.

Espitia FJ. Prevalencia de disfunción sexual en mujeres del Eje Cafetero. Rev.cienc.biomed. 2016;7(1):25-33.

Meston CM. Validation of the Female Sexual Function Index (FSFI) in woman with female orgasmic disorder and in women with hypoactive sexual desire disoder. J Sex Marital Ther. 2003;46:29-39.

Rosen R, Brown C, Heiman J, Leblum S, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191-208.

Bruner DW, Berk L. Altered body image and sexual health. In: Yarbro CH, Frogge MH, Goldman M, eds. Cancer symptom management. Ed 3. Sudbury, MA: Jones and Bartlett 2004.

Hughes M. Oncology patients referred to psychiatry with co-morbid sexual dysfunction. Oncol Nurs Forum. 2007;34:212.

Espitia De La Hoz, FJ. Afectación de la sexualidad en mujeres con prolapso genital y/o incontinencia urinaria. Revista de sexología. 2015;4(2):11-8.

Ganz PA, Greendale GA, Petersen L, et al. Breast cáncer in younger women: reproductive and late health effects of treatment. J Clin Oncol. 2003;21:4184-93.

Cartwright-Alcarese F. Addressing sexual dysfunction following radiation therapy for a gynecologic malignancy. Oncol Nurs Forum. 1995;22:1227-32.

Hughes, M.K. Alterations of sexual function in women with cancer. Seminars in Oncology Nursing. 2008;24(2):91–101.

Schover L. The impact of breast cancer on sexuality, body image, and intimate relationships. CA Cancer J Clin. 1991;41:112-20.

Schover LR, Yetman RJ, Tuasan LJ, et al. Partial mastectomy and breast reconstruction: a comparison of their effects on psychosocial adjustment, body image, and sexuality. Cancer. 1995;75:54-64.

Barni S, Mondin R. Sexual dysfunction in treated breast cancer patients. Ann Oncol. 1997;8:149-53.

Anderson BL, Woods XA, Copeland LJ. Sexual selfschema and sexual morbidity among gynecologic cancer survivors. J Consult Clin Psychol. 1997;65:221-9.

Ekwall E, Ternstedt BM, Sorbet B. Important aspects of health care for women with gynecologic cancer. Oncol Nurs Forum. 2003;30:313-9.

JensenPT, Groenvold M, KleeMC, et al. Longitudinal study of sexual function and vaginal changes after radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2003;56:937-49.

Carmack Taylor CL, Basen-Engquist K, Shinn EH, et al. Predictors of sexual functioning in ovarian cancer patients. J Clin Oncol. 2004;22:881-889.

Espitia FJ. Sexo Ilimitado. El vuelo hacia una sexualidad más placentera. Bogotá. Editorial Bolívar 2015.

Espitia FJ. Mi primer año en “La Crónica”. Bogotá. Editorial Bolívar. 2016.


Enlaces refback

  • No hay ningún enlace refback.


Revista Ciencias Biomedicas
ISSN 2215-7840 / ISSN-e 2389-7252

Universidad de Cartagena
Facultad de Medicina Zaragocilla cra 50C # 24-120

6698177-6698178

correo-e:revistacienciasbiomedicas@unicartagena.edu.co